Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Polymers (Basel) ; 15(15)2023 Jul 28.
Article in English | MEDLINE | ID: mdl-37571119

ABSTRACT

Poly(methylmethacrylate-co-methacrylic acid) (PMMA-co-MAA) polymers were prepared via cobalt-mediated free radical copolymerization and were characterized after synthesis. The synthesis led to a 98.5% conversion and a final ratio between the two units, MMA/MAA, was equal to 63:37 mol%. PMMA-co-MAA was then used as a matrix for cellulose-based nanocomposites to tailor filler compatibility, thanks to the presence of carboxylic groups capable of generating strong H-bonds with the cellulose surface. Cellulose nanofibers (CNFs) were dispersed using a solution with a mixture of two solvents to tailor compatibility of both the components. For this purpose, CNFs were successfully re-dispersed in methanol using the solvent exchange method and tetrahydrofuran/methanol mixtures at different ratios were used for the preparation of the films. Fully transparent films of PMMA-co-MAA + CNF were prepared up to 15 wt% of CNF with a good dispersion in the matrix. This dispersion state leads to the reinforcement of the polymethacrylate matrix, increasing its tensile strength whilst preserving optical transparency.

2.
Macromol Biosci ; 21(8): e2100150, 2021 08.
Article in English | MEDLINE | ID: mdl-34117842

ABSTRACT

Bacterial biofilm-related infections are difficult to eradicate and require repeated treatments with high doses of antibiotics. Thus, there is an urgent need for new treatment strategies that minimize the use of antibiotics while enhancing biofilm eradication. Functionalized reservoir-based microdevices, such as, microcontainers (MCs), offer, high drug loading capacity, mucus embedment, and tuneable drug release. Here, MCs are loaded with the antibiotic ciprofloxacin (CIP), and sealed with a lid consisting of chitosan (CHI) and a mucolytic agent, N-acetylcysteine (NAC). It is found that CHI and NAC work synergistically, showing improved mucoadhesive and mucolytic properties. To better mimic the in vivo habitat of Pseudomonas aeruginosa (P. aeruginosa), the biofilm is grown in a mucin-containing medium on a newly developed centrifugal microfluidic system. The CHI/NAC coated MCs improve eradication of biofilm (88.22 ± 2.89%) compared to CHI-coated MCs (72.68 ± 3.73%) or bolus injection (39.86 ± 13.28%). The findings suggest that MCs are significantly more efficient than a bolus treatment. Furthermore, CHI/NAC functionalized MCs kill most of the biomass already after 5 h (80.75 ± 3.50%), mainly due to a fast drug release. This is the first time that CHI/NAC has been combined as a coating to explore mucolytic properties on bacterial biofilms.


Subject(s)
Anti-Bacterial Agents , Mucins , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Biofilms , Microbial Sensitivity Tests , Pseudomonas aeruginosa
3.
Brain Res Bull ; 65(6): 471-7, 2005 May 30.
Article in English | MEDLINE | ID: mdl-15862918

ABSTRACT

The occurrence of neurogenesis in the hippocampus of the adult rat during trimethyltin (TMT)-induced neurodegeneration was investigated using bromodeoxyuridine (BrdU). Fifteen days after TMT intoxication, BrdU-labeled cells were significantly more numerous in the hippocampus of treated animals, gradually decreasing towards the control value 21 days after intoxication in the dentate gyrus (DG), while in the CA3/hilus region BrdU-labeled cells were still more numerous in TMT-treated rats. In order to investigate the fate of newly-generated cells double labeling experiments using neuronal or glial markers were performed. Colocalization of the neuronal marker NeuN was detected in many BrdU-positive cells in the DG, while in the CA3/hilus region no colocalization of NeuN and BrdU could be observed. No colocalization of BrdU and the astroglial marker GFAP or the microglial marker OX-42 was detected either in the DG and or in the CA3/hilus region. The results indicate an enhancement of endogenous neurogenesis in the hippocampus during TMT-induced neurodegeneration, with the development of a subpopulation of regenerated cells into neurons in the DG, while in the CA3/hilus region the population of newly-generated cells should be regarded as undifferentiated.


Subject(s)
Hippocampus/pathology , Nerve Degeneration/physiopathology , Neurons/physiology , Regeneration/physiology , Animals , Bromodeoxyuridine/metabolism , CD11b Antigen/metabolism , Cell Count/methods , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry/methods , Male , Nerve Degeneration/chemically induced , Nerve Degeneration/pathology , Neurons/drug effects , Phosphopyruvate Hydratase/metabolism , Rats , Rats, Wistar , Staining and Labeling/methods , Trimethyltin Compounds/metabolism
4.
Neurosci Lett ; 357(2): 103-6, 2004 Mar 04.
Article in English | MEDLINE | ID: mdl-15036585

ABSTRACT

In this study we used an immunocytochemical approach to study nestin expression in the rat hippocampus during trimethyltin-induced neurodegeneration at different time points (5, 10, 15, 21 and 50 days) after intoxication. Nestin is transiently expressed by a subpopulation of astroglial cells strictly associated with pyramidal neurons in those hippocampal areas severely affected by degeneration. This observation shows that cerebral tissue re-expresses this developmental protein during neurodegenerative diseases in early stages of astroglial activation.


Subject(s)
Astrocytes/metabolism , Hippocampus/metabolism , Intermediate Filament Proteins/biosynthesis , Nerve Degeneration/metabolism , Nerve Tissue Proteins , Trimethyltin Compounds/toxicity , Animals , Astrocytes/drug effects , Female , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Hippocampus/drug effects , Intermediate Filament Proteins/genetics , Nerve Degeneration/chemically induced , Nestin , Rats , Rats, Wistar
5.
Neurochem Res ; 28(2): 341-5, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12608707

ABSTRACT

S100B is a calcium-binding protein that, in the nervous system, is mainly concentrated in glial cells. Although its biological role is still unclear, the protein is hypothesized, at high concentrations, to act in the pathogenesis of neurodegenerative processes, possibly through oxidative stress mechanisms. To investigate this hypothesis we studied the spinal cord of wobbler mice, an animal model of motor neuron degeneration. Using immunocytochemistry, we detected an overexpression of S100B in astrocytes of the cervical spinal cord of these animals. We also confirmed this finding by reverse transcriptase polymerase chain reaction. In the same spinal cord regions, scattered neurons appeared to be immunostained for 4-hydroxynonenal-modified proteins, an indicator of lipid peroxidation. This finding constitutes a sign of oxidative stress-induced neurodegeneration.


Subject(s)
Aldehydes/metabolism , Nerve Growth Factors/metabolism , S100 Proteins/metabolism , Spinal Cord/metabolism , Animals , Base Sequence , DNA Primers , Immunohistochemistry , Lipid Peroxidation , Mice , Mice, Mutant Strains , Reverse Transcriptase Polymerase Chain Reaction , S100 Calcium Binding Protein beta Subunit
SELECTION OF CITATIONS
SEARCH DETAIL
...